M08.462 Pauciarticular juvenile rheumatoid arthritis, left knee

Name of the Condition

• Pauciarticular Juvenile Rheumatoid Arthritis, Left Knee

Summary

Pauciarticular juvenile rheumatoid arthritis is a subtype of juvenile idiopathic arthritis characterized by inflammation in four or fewer joints during the first six months of disease onset. The "left knee" designation specifies the left knee joint as the site of involvement. This condition primarily affects children and adolescents, with symptoms including joint pain, swelling, and stiffness localized to the left knee. Systemic features may be present but are less prominent than in other subtypes.

Causes

The exact cause is unknown, but it is believed to be an autoimmune disorder where the immune system mistakenly attacks healthy joint tissues. Genetic factors and environmental triggers may contribute to disease development, though specific triggers are not well-defined.

Risk Factors

• Age (most commonly diagnosed in children under 16).
• Female gender (higher prevalence, especially in those with ANA positivity).
• Positive antinuclear antibody (ANA) test, which increases risk of uveitis.
• Family history of autoimmune diseases.

Symptoms

• Joint pain, swelling, and stiffness in the left knee, often worse in the morning.
• Reduced range of motion in the affected left knee.
• Possible eye inflammation (uveitis), which may be asymptomatic initially.
• Limping or reluctance to bear weight on the left leg.

Diagnosis

Diagnosis involves a combination of clinical evaluation, medical history, and diagnostic tests. Physical examination assesses joint involvement, while blood tests (e.g., inflammatory markers, ANA) and imaging (e.g., X-rays, MRI) help confirm the diagnosis and rule out other conditions. Joint fluid analysis may be performed to evaluate for inflammation.

Treatment Options

Treatment focuses on reducing inflammation, preserving joint function, and managing symptoms. Options include nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and biologic agents. Physical therapy and occupational therapy may be recommended to maintain mobility and strength. In some cases, corticosteroid injections into the joint may be used for localized relief.

Prognosis and Follow-Up

Prognosis varies, but many children achieve remission with appropriate treatment. Regular follow-up is essential to monitor disease activity, adjust therapy, and screen for complications such as uveitis. Long-term management may be necessary to prevent joint damage and maintain quality of life.

Complications

• Joint damage or deformity in the left knee.
• Chronic pain or stiffness.
• Eye inflammation (uveitis), which can lead to vision problems if untreated.
• Growth disturbances in severe or prolonged cases.

Lifestyle & Prevention

• Maintain a balanced diet to support overall health.
• Engage in low-impact exercises (e.g., swimming) to preserve joint function.
• Protect the left knee from excessive strain during activities.
• Follow prescribed treatment plans consistently.

When to Seek Professional Help

Seek medical attention if symptoms worsen, new joint involvement occurs, or signs of uveitis (e.g., eye pain, redness) develop. Prompt evaluation is important to adjust treatment and prevent complications.

Tips for Medical Coders

Document the specific joint involvement (left knee) and confirm the pauciarticular subtype criteria (four or fewer joints affected within six months of onset). Ensure clinical documentation supports the diagnosis and site specificity for accurate coding.